Holen Sie sich die Stockscreener-App
17.39
1.34%
0.23
Handel nachbörslich:
17.57
0.18
+1.04%
Uniqure N V Aktie (QURE) Neueste Nachrichten
uniQure N.V. Faces Class Action Lawsuit Deadline - National Today
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
QURE Investors Have Opportunity to Lead uniQure N.V. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
UniQure NV (NASDAQ:QURE) Q4 2025 earnings call transcript - MSN
ROSEN, A LEADING NATIONAL FIRM, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
UNIQURE DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages uniQure N.V. Investors ... - Caledonian Record
UNIQURE DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - GlobeNewswire Inc.
INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO - GlobeNewswire Inc.
UniQure used 'distorted comparison' in Huntington's asset trial: FDA official - msn.com
uniQure Faces FDA Rebuke as Shareholder Class Action Filed - Intellectia AI
uniQure Approaches April 13 Court Deadline Amid Stricter FDA Position on Gene Therapy Study - Bitget
(QURE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
QURE 9-DAY DEADLINE ALERT: Hagens Berman Updates uniQure - GlobeNewswire
QURE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - PR Newswire
Aberdeen Group plc Acquires 738,897 Shares of uniQure N.V. $QURE - MarketBeat
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V.QURE - Sahm
uniQure N.V. (NASDAQ:QURE) Receives Average Recommendation of "Moderate Buy" from Analysts - marketbeat.com
uniQure N.V. Class Action Reminder - National Today
uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm fo - PharmiWeb.com
uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights - The Daily Tribune News
FinancialContentuniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights - markets.financialcontent.com
QURE ALERT: Hagens Berman Updates uniQure (QURE) Probe After FDA Criticism; April 13 Deadline Nears - PR Newswire
UniQure surges following departure of key FDA official - MSN
QURE Deadline: QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit - Sahm
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - accessnewswire.com
UNIQURE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure ... - Caledonian Record
UNIQURE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - GlobeNewswire Inc.
UNIQURE DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. - GlobeNewswire
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
2026-04-02 | QURE SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 | NDAQ:QURE | Press Release - Stockhouse
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming DeadlinesQURE - PR Newswire
uniQure (QURE) Loses 67.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Eastern Progress
Barclays reaffirms equal weight rating for uniQure (QURE) - MSN
Levi & Korsinsky Reminds uniQure N.V. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 13, 2026QURE - PR Newswire
Rare disease advocacy group urges Trump administration to restore FDA clarity - MarketScreener
Barclays Reaffirms Equal Weight Rating for uniQure (QURE) - Insider Monkey
uniQure Investors File Class Action Lawsuit Over FDA Approval Delay - Intellectia AI
uniQure N.V. Securities Fraud Class Action Result of FDA - GlobeNewswire
QURE jumps 20% – analysts upgrade stock on Huntington’s disease therapy update, retail eyes $150 - MSN
Hemophilia B Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk - Barchart.com
QURE Shareholder Alert: uniQure N.V. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Deadline Approaching for uniQure N.V. Class Action Lawsuit - National Today
Contact Levi & Korsinsky by April 13, 2026 Deadline to Join Class Action Against uniQure N.V. (QURE) - GlobeNewswire
QURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data - PR Newswire
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz - GuruFocus
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline - PR Newswire
March 2026: Pharmacological advancements in rare diseases - The Pharma Letter
uniQure N.V. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsQURE - ChartMill
QURE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
Rosen Law Firm Encourages uniQure Investors to Secure Counsel Before Deadline - National Today
ROSEN Firm Encourages uniQure Investors to Secure Counsel - National Today
ROSEN, A TRUSTED AND LEADING INVESTOR RIGHTS FIRM, Encourages uniQure N.V. Investors to Secure ... - Caledonian Record
ROSEN, A TRUSTED AND LEADING INVESTOR RIGHTS FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
uniQure N.V. (QURE): A Bull Case Theory - MSN
uniQure (NASDAQ:QURE) Raised to Hold at Wall Street Zen - MarketBeat
UniQure NV (QURE) price target decreased by 26.57% to 37.82 - MSN
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit - ChartMill
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):